Brendan R. Winslow

Chief Financial Officer, Atrium Therapeutics, Inc.

Companies

Atrium Therapeutics, Inc.Chief financial officer Feb 26, 2026 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Atrium Therapeutics, Inc. RNA36,859 shares²$284.6K at $7.72Sep 18, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 18, 2026Shares withheld for tax 6,742 shares at $8.95 of Atrium Therapeutics, Inc.²
Apr 20, 2026Granted 30,000 shares of Atrium Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAtrium Therapeutics, Inc., Chief financial officer
2
SEC EDGARAtrium Therapeutics, Inc. shares after the filing of Sep 18, 2026
3
SEC EDGARForm 4 filed Apr 22, 2026